Screening for colorectal cancer in ulcerative colitis

Por Broström, Olle, Karlen, Per, Löfberg, Robert
Publicado em 1991

Mesalazine-induced renal calculi

Por Jacobsson, Henrik, Eriksen, Jaran, Karlén, Per
Publicado em 2013

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease

Por Karlsson Mats, Eberhardson Michael, Lindberg Annelie, Karlén Per
Publicado em 2010-07-01

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease

Por Lindberg, Annelie, Eberhardson, Michael, Karlsson, Mats, Karlén, Per
Publicado em 2010

Inflammatory bowel disease professionals’ attitudes to and experiences of complementary and alternative medicine

Por Lindberg, Annelie, Ebbeskog, Britt, Karlen, Per, Oxelmark, Lena
Publicado em 2013

Experiences of complementary and alternative medicine in patients with inflammatory bowel disease – a qualitative study

Por Lindberg, Annelie, Fossum, Bjöörn, Karlen, Per, Oxelmark, Lena
Publicado em 2014

CCR9-expressing CD14+HLA-DR(hi) blood monocytes promote intestinal inflammation in IBD

Por Linton, Ludvig, Karlsson, Mats, Grundström, Jeanette, Marits, Per, Lindberg, Annelie, Karlen, Per, Winqvist, Ola, Eberhardson, Michael
Publicado em 2011

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study

Por Oxelmark, Lena, Lindberg, Annelie, Löfberg, Robert, Sternby, Berit, Eriksson, Anders, Almer, Sven, Befrits, Ragnar, Fossum, Bjöörn, Karlén, Per, Broström, Olle, Tysk, Curt
Publicado no Eur J Gastroenterol Hepatol (2016)

HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD

Por Linton, Ludvig, Karlsson, Mats, Grundström, Jeanette, Hjalmarsson, Eric, Lindberg, Annelie, Lindh, Emma, Glise, Hans, Befrits, Ragnar, Janczewska, Izabella, Karlén, Per, Winqvist, Ola, Eberhardson, Michael
Publicado em 2012

A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease

Por Keshav, Satish, Vaňásek, Tomáš, Niv, Yaron, Petryka, Robert, Howaldt, Stephanie, Bafutto, Mauro, Rácz, István, Hetzel, David, Nielsen, Ole Haagen, Vermeire, Séverine, Reinisch, Walter, Karlén, Per, Schreiber, Stefan, Schall, Thomas J., Bekker, Pirow
Publicado em 2013